Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
14,280.00    -38.00 (-0.27%)
Bid:
14,280.00
Ask:
14,282.00
Spread: 2.00 (0.014%)
Market Cap: £221.46b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

AstraZeneca's Tagrisso gets new US lung cancer approval
26 Sep 2024

AstraZeneca's Tagrisso gets new US lung cancer approval

(Sharecast News) - AstraZeneca announced on Thursday that 'Tagrisso', or osimertinib, has been approved by the US Food and Drug Administration (FDA) f...

Pfizer, Moderna and BioNTech take patent fight to Court of Appeal
25 Sep 2024

Pfizer, Moderna and BioNTech take patent fight to Court of Appeal

(Alliance News) - A multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents is set to continue at th...

London stocks close up as resources-linked shares rise
23 Sep 2024

London stocks close up as resources-linked shares rise

FTSE 100 up 0.4%, FTSE 250 adds 0.1% *

London close: Stocks finish higher after slew of PMI data
23 Sep 2024

London close: Stocks finish higher after slew of PMI data

(Sharecast News) - London's stock markets ended Monday on a positive note, as investors pored over a number of economic activity reports from both the...

TOP NEWS: AstraZeneca cancer drug fails to significantly extend lives
23 Sep 2024

TOP NEWS: AstraZeneca cancer drug fails to significantly extend lives

(Alliance News) - AstraZeneca PLC on Monday said a breast cancer drug failed to significantly extend patients' lives, a second blow this month to hope...

LONDON BRIEFING: REA ups Rightmove bid; AstraZeneca in trial blow
23 Sep 2024

LONDON BRIEFING: REA ups Rightmove bid; AstraZeneca in trial blow

(Alliance News) - Stocks in London are to open higher on Monday, ahead of flash composite purchasing managers' index data from the US, the UK and main...

AstraZeneca breast cancer drug trial fails to improve overall survival
23 Sep 2024

AstraZeneca breast cancer drug trial fails to improve overall survival

(Sharecast News) - AstraZeneca updated the market on two ongoing drug trials on Monday, with a key trial in breast cancer failing to improve survival.